Ticker Details
Tempest Therapeutics, Inc.
IPO Date:	December 7, 2012
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$22.66M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.21 | 4.88%
Avg Daily Range (30 D):	$0.07 | 3.73%
Avg Daily Range (90 D):	$0.08 | 3.29%

Institutional Daily Volume
Avg Daily Volume:	1M
Avg Daily Volume (30 D):	.16M
Avg Daily Volume (90 D):	.12M

Trade Size
Avg Trade Size (Sh.):	209
Avg Trade Size (Sh.) (30 D):	144
Avg Trade Size (Sh.) (90 D):	126

Institutional Trades
Total Institutional Trades:	58
Avg Institutional Trade:	$1.06M
Avg Institutional Trade (30 D):	$.82M
Avg Institutional Trade (90 D):	$.82M
Avg Institutional Trade Volume:	.04M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$1.29M
Avg Closing Trade (30 D):	$1.31M
Avg Closing Trade (90 D):	$1.31M
Avg Closing Volume:	23.51K

News

Mar 11, 2026 @ 12:00 PM Tempest Announces Partnership for TPST-2003 in Pre... Source: Na

Nov 19, 2025 @ 2:00 PM Tempest Announces Strategic Acquisition of New Dua... Source: Globe Newswire

Nov 19, 2025 @ 2:00 PM Tempest Announces Strategic Acquisition of New Dua... Source: Tempest Therapeutics

Sep 25, 2025 @ 5:00 PM Advanced Liver Cancer Clinical Trial Pipeline Show... Source: Delveinsight

Feb 7, 2025 @ 9:30 PM Tempest Reports Inducement Grant Under Nasdaq List... Source: N/A

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$-6.33	$-.62	$-6.33
Diluted EPS	$-6.33	$-.62	$-6.33
Revenue
Gross Profit
Net Income / Loss	$-26.26M	$-4.02M	$-26.26M
Operating Income / Loss	$-26.58M	$-4.08M	$-26.58M
Cost of Revenue
Net Cash Flow	$M	$M	$M
PE Ratio

Splits
Jan 30, 2026	2:1
Apr 09, 2025	1:13
Jun 28, 2021	1:15